Optimal length of oral anticoagulant treatment for maximum benefit within 5 years after discontinuation of oral anticoagulants in patients with acute pulmonary embolism who require secondary thromboprophylaxis

BACKGROUND: Extended oral anticoagulant (OA) use is recommended in patients with acute pulmonary embolism (PE) who require secondary thromboprophylaxis. Nevertheless, the optimal length of OA use for the maximum long-term benefit in this patient population has been undefined to date. METHODS: A retr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yunfeng, Luo, Yong, Cheng, Yi, Wang, Hongwei, Du, He, Sun, Jinyuan, Xu, Mei, Xiong, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Pulmonary Vasculature
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441053/
https://www.ncbi.nlm.nih.gov/pubmed/37597971
http://dx.doi.org/10.1136/bmjresp-2023-001856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441053/
https://www.ncbi.nlm.nih.gov/pubmed/37597971
http://dx.doi.org/10.1136/bmjresp-2023-001856

Ejemplares similares